首页> 外文期刊>Clinical rheumatology >C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population
【24h】

C-reactive protein (CRP) polymorphisms and haplotypes are associated with SLE susceptibility and activity but not with serum CRP levels in Mexican population

机译:C-反应蛋白(CRP)多态性和单倍型与SLE易感性和活性相关,但在墨西哥人群中没有血清CRP水平

获取原文
获取原文并翻译 | 示例
           

摘要

To evaluate the association of C-reactive protein (CRP) polymorphisms with risk of development SLE in a group of Mexican individuals. Five CRP polymorphisms (rs3093059, rs3093062, rs1800947, rs1130864, and rs1205) were determined by PCR-restriction fragment length polymorphism and SNP rs3093061 by refractory mutation system PCR assay in 126 SLE patients and 131 controls. Four of the polymorphisms showed differences between patients and controls. rs3093061 polymorphism was associated with a lower risk of developing lupus principally in the codominant 2 (OR = 0.219, 95% CI 0.108-0.785, P = 0.015) model. rs1130864 was associated with decreased risk mainly under codominant 1 (OR = 0.288, 95% CI 0.143-0.581, P = 0.001) model. rs1205 was associated under the over-dominant model (OR = 0.504, 95% CI 0.270-0.942, P = 0.032). The rs3091244 polymorphism was associated with decreased risk of SLE mostly under additive (OR = 0.605, 95% CI 0.393-0.931. P = 0.022) model. Our study establishes that rs3093061, rs1130864, rs1205, and rs3091244 polymorphisms are associated with decreased risk of developing SLE.
机译:评估C反应蛋白(CRP)多态性与在一组墨西哥人群中发育的风险。通过PCR限制性片段长度多态性和SNP RS3093061在126患者和131例对照中通过PCR限制性片段长度多态性和SNP RS3093061确定了五种CRP多态性(RS3093059,RS3093062,RS1130864和RS11205)。四种多态性在患者和对照之间表现出差异。 RS3093061多态性与主要在Codominant 2(或= 0.219,95%CI 0.108-0.785,P = 0.015)模型中较低的狼疮的风险较低。 RS1130864与主要在Codominant 1(或= 0.288,95%CI 0.143-0.581,P = 0.001)模型中的风险降低有关。 RS1205在过度显性模型(或= 0.504,95%CI 0.270-0.942,P = 0.032)下有关。 RS3091244多态性与大多数在添加剂(或= 0.605,95%CI 0.393-0.931。P = 0.022)的模型中,RS3091244多态性与微小的风险降低有关。我们的研究确定了RS3093061,RS1130864,RS1205和RS3091244多态性与开发SLE的风险降低有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号